Physician profile
Jennifer E Mitkowski
NPI 1518281989
$1,753.24
in general payments reported to CMS, 2019-2025
29 companies · $20.33 in 2025
The $20.33 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,155 · 2022: $510 · 2023: $68.16 · 2025: $20.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $486.04 | 2021-2023 | |
| Novo Nordisk INC | $252.04 | 2021-2022 | |
| Lilly USA, LLC | $112.91 | 2021-2022 | |
| Amgen INC. | $97.92 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $85.86 | 2021-2022 | |
| Optinose US, INC. | $66.89 | 2021-2022 | |
| Eisai INC. | $58.71 | 2021 | |
| Boston Scientific Corporation | $51.78 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Takeda Pharmaceuticals U.S.A., INC. | $43.46 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.53 | 2022 | |
| Glaxosmithkline, LLC. | $41.09 | 2021 | |
| Merck Sharp & Dohme LLC | $37.55 | 2021-2022 | |
| Lucid Diagnostics INC. | $33.25 | 2021-2022 | |
| Philips North America LLC | $32.95 | 2022 | |
| Pfizer INC. | $31.55 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $31.14 | 2021 | |
| Clarus Therapeutics INC. | $27.17 | 2021 | |
| Esperion Therapeutics, INC. | $26.68 | 2021 | |
| Corium, LLC | $21.80 | 2022 | |
| Sanofi Pasteur INC. | $21.34 | 2021 | |
| Jazz Pharmaceuticals INC. | $20.78 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $20.57 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.45 | 2021 | |
| Alkermes, INC. | $17.10 | 2022 | |
| Ibsa Pharma INC. | $16.69 | 2021 | |
| Cranial Technologies, INC | $15.37 | 2021 | |
| Antares Pharma, INC. | $14.89 | 2021 | |
| Currax Pharmaceuticals LLC | $13.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Mitkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.